ACHN
T. Rowe Price Associates’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,478,326
| Closed | -$16.5M | – | 2599 |
|
|
2018
Q3 | $16.5M | Sell |
4,478,326
-100,747
| -2% | -$371K | ﹤0.01% | 1279 |
|
|
2018
Q2 | $13M | Sell |
4,579,073
-79,883
| -2% | -$226K | ﹤0.01% | 1300 |
|
|
2018
Q1 | $17.3M | Buy |
+4,658,956
| New | +$17.3M | ﹤0.01% | 1229 |
|
|
2017
Q4 | – | Sell |
-25,228
| Closed | -$113K | – | 2622 |
|
|
2017
Q3 | $113K | Hold |
25,228
| – | – | ﹤0.01% | 2470 |
|
|
2017
Q2 | $116K | Sell |
25,228
-44,741
| -64% | -$206K | ﹤0.01% | 2465 |
|
|
2017
Q1 | $295K | Hold |
69,969
| – | – | ﹤0.01% | 2267 |
|
|
2016
Q4 | $289K | Sell |
69,969
-2,931,770
| -98% | -$12.1M | ﹤0.01% | 2263 |
|
|
2016
Q3 | $24.3M | Sell |
3,001,739
-1,865,180
| -38% | -$15.1M | ﹤0.01% | 1062 |
|
|
2016
Q2 | $38M | Buy |
4,866,919
+71,712
| +1% | +$559K | 0.01% | 882 |
|
|
2016
Q1 | $37M | Buy |
4,795,207
+735,088
| +18% | +$5.67M | 0.01% | 886 |
|
|
2015
Q4 | $43.8M | Buy |
4,060,119
+11,900
| +0.3% | +$128K | 0.01% | 812 |
|
|
2015
Q3 | $28M | Buy |
4,048,219
+3,844,716
| +1,889% | +$26.6M | 0.01% | 971 |
|
|
2015
Q2 | $1.8M | Buy |
+203,503
| New | +$1.8M | ﹤0.01% | 1610 |
|
|
2014
Q2 | – | Sell |
-27,400
| Closed | -$90K | – | 2558 |
|
|
2014
Q1 | $90K | Sell |
27,400
-22,600
| -45% | -$74.2K | ﹤0.01% | 2443 |
|
|
2013
Q4 | $166K | Sell |
50,000
-10,700
| -18% | -$35.5K | ﹤0.01% | 2350 |
|
|
2013
Q3 | $183K | Sell |
60,700
-1,962,700
| -97% | -$5.92M | ﹤0.01% | 2294 |
|
|
2013
Q2 | $16.6M | Buy |
+2,023,400
| New | +$16.6M | ﹤0.01% | 1117 |
|